comparemela.com
Home
Live Updates
Mental Health Surveillance Study - Breaking News
Pages:
Mental Health Surveillance Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Vistagen Announces Completion of Last Patient, Last Visit in Phase 2 Clinical Trial of PH94B for the Treatment of Adjustment Disorder with Anxiety
Topline results of the exploratory Phase 2 clinical study anticipated in Q1 2023 . | January 10, 2023
New york
United states
Columbia university
New york state psychiatric institute
Shawn singh
Michael liebowitz
Mental health surveillance study
York state psychiatric institute
Research network
Hamilton anxiety rating scale
Anxiety disorders clinic
Medical research network
New york city
Principal investigator
Chief executive officer
Vistagen therapeutics
vimarsana © 2020. All Rights Reserved.